Cardinal Health, Inc. (NYSE:CAH) Q4 2025 Earnings Conference Call August 12, 2025 8:30 AM ET
Company Participants
Aaron E. Alt – Chief Financial Officer
Jason M. Hollar – CEO & Director
Matt Sims – Vice President of Investor Relations
Conference Call Participants
Allen Charles Lutz – BofA Securities, Research Division
Brian Gil Tanquilut – Jefferies LLC, Research Division
Charles Rhyee – TD Cowen, Research Division
Daniel R. Grosslight – Citigroup Inc., Research Division
Elizabeth Hammell Anderson – Evercore ISI Institutional Equities, Research Division
Eric R. Percher – Nephron Research LLC
Erin Elizabeth Wilson Wright – Morgan Stanley, Research Division
George Robert Hill – Deutsche Bank AG, Research Division
Kevin Caliendo – UBS Investment Bank, Research Division
Lisa Christine Gill – JPMorgan Chase & Co, Research Division
Michael Aaron Cherny – Leerink Partners LLC, Research Division
Stephen C. Baxter – Wells Fargo Securities, LLC, Research Division
Steven James Valiquette – Mizuho Securities USA LLC, Research Division
Operator
Hello, and welcome to the Fourth Quarter Fiscal Year 2025 Cardinal Health Inc. Earnings Conference Call. My name is George. I’ll be the coordinator for today’s event. Please note that this conference is being recorded. [Operator Instructions]
I’d like to hand the call over to your host today, Mr. Matt Sims, Vice President, Investor Relations, to begin today’s conference. Please go ahead, sir.
Matt Sims
Good morning, and welcome to Cardinal Health’s fourth quarter fiscal ’25 earnings conference call, and thank you for joining us. With me today are Cardinal Health, CEO, Jason Hollar; and our CFO, Aaron Alt. You can find this morning’s earnings press release and investor presentation on the Investor Relations section of our website at ir.cardinalhealth.com.
Since we will be making forward-looking statements today, let me remind you that the matters addressed in these statements are subject to risks and uncertainties
#Cardinal #Health #CAH #Earnings #Call #Transcript